Rectal neuroendocrine neoplasms (r-NENs) are considered among the most frequent
digestive NENs, together with small bowel NENs. Their incidence has increased over the …

Neuroendocrine tumors (NETs) encompass a range of pathologies and behaviors, ranging
from indolent tumors often discovered incidentally, to poorly differentiated and aggressive …

Rectal neuroendocrine tumors (RNET) are rare tumors but their prevalence is constantly
increasing due to a prolonged survival and rising incidence related to a growing number of …

The incidence gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) has
dramatically risen over the last three decades, probably due to the increased detection of …

Background: The number of patients diagnosed with rectal neuroendocrine tumors (R-NETs)
is increasing year by year. An integrated survival predictive model is required to predict the …

Abstract Background/Objective Staging and type of resection for rectal neuroendocrine
tumors (R‐NETS) relies on preoperative identification of lymph node (LN) involvement …

Abstract Background Rectal neuroendocrine tumors (RNETs) are often discovered on
screening colonoscopy. Indications for staging and definitive resection are inconsistent in …

Neuroendocrine neoplasms of the rectum (R-NENs) are rare; however, their incidence has
increased almost threefold in the last few decades. Imaging of R-NENs includes two primary …

Abstract Background The American Joint Commission on Cancer, the European
Neuroendocrine Tumor Society, and the North American Neuroendocrine Tumor Society all …

Background: Rectal neuroendocrine tumors (rNENs) are rare, constituting 1–2% of rectal
tumors, and are often asymptomatic, leading to challenges in early diagnosis. Current …